institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Survey Reveals High Vaccine Hesitancy Among Pregnant Women and New Mothers

UNITED KINGDOM, JUL 18 – Vaccinating pregnant women with the respiratory syncytial virus vaccine reduced infant hospitalizations by 72%, according to a UK study of 537 babies during winter 2024-25.

  • Researchers at the Universities of Edinburgh and Leicester found a 72% reduction in hospitalizations among infants, following uptake of the RSV vaccine introduced across the UK in late summer 2024.
  • Respiratory syncytial virus is a leading cause of infant respiratory illness, and maternal antibodies passed to the fetus provide protection for first six months of life.
  • Among the babies enrolled, 391 tested positive for RSV, and mothers of uninfected babies were twice as likely to have been vaccinated before delivery.
  • Uptake remains low as only about half of expectant mothers in England and Scotland are receiving the RSV vaccine, and experts say increased uptake could ease winter hospital pressures.
  • Recommendations state that experts recommend administering the vaccine from 28 weeks of pregnancy to maximise antibody transfer, and maternal immunization protects infants during their early, vulnerable months.
Insights by Ground AI
Does this summary seem wrong?

17 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 82% of the sources are Center
82% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Friday, July 18, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.